Introduction. Several evidence-based documents on the use of electroconvulsive therapy (ECT) indicate that it is a safe and effective treatment for a variety of psychiatric disorders. 1–3 Although major depression refractory to antidepressant medications is the primary indication for ECT, there is also significant evidence to support its use in other psychiatric disorders such as catatonia Aim: The goal was to determine if use of gabapentin could assist with management of myalgia and anxiety in a patient treated with Electroconvulsive therapy (ECT) for depression, without interfering with seizure activity during ECT. Electroconvulsive therapy (ECT) has demonstrated to be highly effective and safe, even life saving for many psychiatric disorders such as major depression, bipolar disorder and schizophrenia. Most patients who require ECT are also on concurrent pharmacotherapy. A MEDLINE search (1985-2006) was performed, using the terms "electroconvulsive therapy," "anticonvulsants," "epilepsy," "carbamazepine," "gabapentin," "lamotrigine," "topiramate," and "valproate," supplemented by manual searches of guidelines and textbooks on ECT. Electroconvulsive therapy (ECT) is a clinical procedure where a small dose of electric current is passed through the brain for a brief period to induce seizures for therapeutic purposes in psychiatric (and certain neurological) conditions. There are refractory cases of somatic symptom disorder in which symptom burden remains high despite multiple therapeutic approaches. Electroconvulsive therapy (ECT) is indicated for refractory depression, bipolar disorder, and schizophrenia, and there are several case reports highlighting ECT for the treatment of somatic symptom disorder. Gabapentin appears to be a promising adjunct during ECT to manage anxiety and myalgia as it did not interfere with seizure duration or clinical effect on depression. This chapter reviews the evidence for interactions between concomitantly taken drugs and ECT, concentrating on safety issues and their management, but also commenting on therapeutic interactions where relevant. Aim: The goal was to determine if use of gabapentin could assist with management of myalgia and anxiety in a patient treated with Electroconvulsive therapy (ECT) for depression, without This pharmacoepidemiological study was undertaken to determine if the combination of electroconvulsive therapy (ECT) and the anticonvulsants valproate (VPA) or carbamazepine (CBZ) is safe and Electroconvulsive therapy (ECT) is an effective therapeutic option for treatment-resistant depression (TRD). [Paganin D et al., 2004] In this article, we summarise the recently published RANZCP guidelines which provide the most up to date guidance on ECT. [Weiss A et al., 2019] Electroconvulsive therapy (ECT) is a psychiatric treatment for severe mental illness (emphasis on bipolar disorder, depression, suicidality, and catatonia) that involves passing small electric currents through the brain to induce a brief seizure or convulsion. This is often saved for patients This article was first published on February 4, 2023. It was last reviewed/ updated on February 7, 2023. Question from a Member: If a patient is on gabapentin and clonazepam, would they have to taper off of these to be able to start ECT? There are two main reasons why this question is clinically important. The literature that is currently available indicates that ECT can be safely and effectively administered to patients treated with various AC. There is, however, no evidence to combine the 2 treatment modalities to augment therapeutic efficacy. Electroconvulsive therapy (ECT) is an effective treatment for severe psychiatric disorders. Patients referred to ECT are often taking multiple medications, many of which can potentially affect the safety and efficacy of their course of ECT. This review evaluates the impact of a variety of psychotropic medications often used in conjunction with ECT and examines strategies to optimize their Electroconvulsive therapy (ECT) depends on the seizure threshold, so you don’t want to throw that off before starting it. Anticonvulsants and benzodiazepines are concerning, as are antidepressants. PDF | On Jan 10, 2015, Stephanie Peglow and others published Use of Gabapentin during ECT for Myalgia and Anxiety: Effects on Seizure Activity | Find, read and cite all the research you need on The procedure (ECT) Electroconvulsive Therapy (ECT) is a noninvasive brain stimulation technology. The ECT device delivers predetermined electrical pulses to the brain resulting in a controlled generalized seizure that exerts biological effects that translate into clinical benefit. The goal of medication management in such cases is to achieve adequate seizure (eg, 30 to 90 seconds) during ECT without causing spontaneous seizures. 4, 5 ECT is often delivered using brief pulse Pre-ECT neurology consultations are often requested to determine the relative risk of the procedure in patients with neurological comorbidities, but there is limited data to guide clinicians. The authors performed a retrospective chart review of all consecutive inpatients at McLean Hospital who underwent a pre-ECT neurological evaluation between January 2012 and June 2014 (N=68). ECT was safe
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |